Virtus LifeSci Biotech Clinical Trials ETF
14 hedge funds and large institutions have $3.78M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$291K |
| 2 |
2
Jane Street
New York
|
$280K |
| 3 |
3
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$190K |
| 4 |
SG
4
Societe Generale
|
$151K |
| 5 |
5
SG Americas Securities
New York
|
$151K |
